
CLYM
Climb Bio Inc.
$7.05
+$0.18(+2.62%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$134.32M
Volume
285.25K
52W Range
$1.05 - $8.04
Target Price
$15.36
Company Overview
| Mkt Cap | $134.32M | Price | $7.05 |
| Volume | 285.25K | Change | +2.62% |
| P/E Ratio | -1.8 | Open | $7.10 |
| Revenue | $100.0K | Prev Close | $6.87 |
| Net Income | $-73.9M | 52W Range | $1.05 - $8.04 |
| Div Yield | N/A | Target | $15.36 |
| Overall | 63 | Value | 60 |
| Quality | -- | Technical | 66 |
No chart data available
Latest News
Climb Bio Consolidates Financial Leadership After SVP Departure
TipRanks Auto-Generated Newsdesk•5 days ago
Analysts’ Top Healthcare Picks: Climb Bio (CLYM), Nektar Therapeutics (NKTR)
Catie Powers•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLYM | $7.05 | +2.6% | 285.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |